Human Gene Set: GSE1460_DP_VS_CD4_THYMOCYTE_DN


Standard name GSE1460_DP_VS_CD4_THYMOCYTE_DN
Systematic name M3454
Brief description Genes down-regulated in comparison of CD4 [GeneID=920] CD8 thymocytes versus T cells from cord blood.
Full description or abstract Subpopulations of human fetal thymocyte and circulating naïve T cells were obtained through FACS sorting, including CD3-CD4+CD8- intrathymic T progenitor cells (ITTP), CD3intCD4+CD8+ \double positive\ thymocytes (DP), CD3highCD4+CD8- \single positive\ thymocytes (SP4), CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from cord blood (CB4+), and CD3+CD4+CD8-CD45RA+CD62L+ naive T cells from adult blood (AB4+).
Collection C7: Immunologic Signature
      IMMUNESIGDB: ImmuneSigDB
Source publication Pubmed 15210650   Authors: Lee MS,Hanspers K,Barker CS,Korn AP,McCune JM
Exact source GSE1460_2138_200_DN
Related gene sets (show 37 additional gene sets from the source publication)

(show 14 gene sets from the same authors)
External links
Filtered by similarity ?
Source species Homo sapiens
Contributed by Jernej Godec (Dana-Farber Cancer Institute)
Source platform or
identifier namespace		 HUMAN_GENE_SYMBOL
Dataset references (show 1 datasets)
Download gene set format: grp | gmt | xml | json | TSV metadata
Compute overlaps ? (show collections to investigate for overlap with this gene set)
Compendia expression profiles ? NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)

Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Advanced query Further investigate these 200 genes
Gene families ? Categorize these 200 genes by gene family
Show members (show 200 source identifiers mapped to 200 genes)
Version history 7.3: Moved to ImmuneSigDB sub-collection.

See MSigDB license terms here. Please note that certain gene sets have special access terms.